Healthcare of Ontario Pension Plan Trust Fund Trims Stock Holdings in Lumexa Imaging Holdings, Inc. $LMRI

Healthcare of Ontario Pension Plan Trust Fund lowered its holdings in shares of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) by 13.3% in the first quarter, Holdings Channel.com reports. The fund owned 1,300,000 shares of the company’s stock after selling 200,000 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Lumexa Imaging were worth $11,180,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Assetmark Inc. bought a new stake in shares of Lumexa Imaging during the fourth quarter worth $36,000. Geode Capital Management LLC bought a new position in shares of Lumexa Imaging in the fourth quarter worth about $1,548,000. Seven Grand Managers LLC purchased a new position in Lumexa Imaging in the 4th quarter worth about $11,942,000. Goldman Sachs Group Inc. purchased a new stake in Lumexa Imaging in the 4th quarter valued at about $18,870,000. Finally, TD Asset Management Inc bought a new position in Lumexa Imaging in the 4th quarter worth about $1,264,000.

Lumexa Imaging Trading Down 0.7%

Shares of NASDAQ:LMRI opened at $10.97 on Wednesday. The stock has a market cap of $1.05 billion and a P/E ratio of -18.59. The company has a debt-to-equity ratio of 1.43, a current ratio of 1.40 and a quick ratio of 1.40. Lumexa Imaging Holdings, Inc. has a 12-month low of $6.45 and a 12-month high of $19.45. The firm has a fifty day moving average of $9.95.

Insider Transactions at Lumexa Imaging

In related news, Director Brett Brodnax acquired 35,000 shares of the business’s stock in a transaction dated Tuesday, May 19th. The shares were purchased at an average price of $7.25 per share, for a total transaction of $253,750.00. Following the completion of the acquisition, the director directly owned 62,027 shares in the company, valued at $449,695.75. The trade was a 129.50% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on LMRI shares. Wall Street Zen raised Lumexa Imaging from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. Barclays dropped their price target on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 20th. Finally, Weiss Ratings upgraded Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a report on Thursday, June 25th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $16.00.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).